301257 Stock Overview
Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
SMO ClinPlus CO.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥28.72 |
| 52 Week High | CN¥57.85 |
| 52 Week Low | CN¥25.16 |
| Beta | 0.72 |
| 11 Month Change | 10.08% |
| 3 Month Change | -21.23% |
| 1 Year Change | -29.06% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -49.98% |
Recent News & Updates
Little Excitement Around SMO ClinPlus CO.,LTD.'s (SZSE:301257) Earnings As Shares Take 37% Pounding
Jun 06
SMO ClinPlusLTD's (SZSE:301257) Promising Earnings May Rest On Soft Foundations
May 05Shareholder Returns
| 301257 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 3.0% | 8.1% | 0.4% |
| 1Y | -29.1% | -35.0% | -21.0% |
Return vs Industry: 301257 exceeded the CN Life Sciences industry which returned -35% over the past year.
Return vs Market: 301257 underperformed the CN Market which returned -21% over the past year.
Price Volatility
| 301257 volatility | |
|---|---|
| 301257 Average Weekly Movement | 5.6% |
| Life Sciences Industry Average Movement | 6.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 301257's share price has been volatile over the past 3 months.
Volatility Over Time: 301257's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 4,407 | n/a | www.smo-clinplus.com |
SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company’s SMO services incudes preliminary model establishment, preliminary plan preparation, initiation of clinical trial sites, on-site implementation, and project management services.
SMO ClinPlus CO.,LTD. Fundamentals Summary
| 301257 fundamental statistics | |
|---|---|
| Market cap | CN¥2.33b |
| Earnings (TTM) | CN¥132.14m |
| Revenue (TTM) | CN¥787.42m |
17.3x
P/E Ratio2.9x
P/S RatioIs 301257 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301257 income statement (TTM) | |
|---|---|
| Revenue | CN¥787.42m |
| Cost of Revenue | CN¥548.22m |
| Gross Profit | CN¥239.21m |
| Other Expenses | CN¥107.06m |
| Earnings | CN¥132.14m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 1.66 |
| Gross Margin | 30.38% |
| Net Profit Margin | 16.78% |
| Debt/Equity Ratio | 0% |
How did 301257 perform over the long term?
See historical performance and comparison